Capricorn shareholders push for NewMed deal to be axed


Issue 475 - 23 Dec 2022 - By Marc Howard | 2 minute read

Criticism of the acquisition of London Stock Exchange (LSE)-listed Capricorn Energy by Tel Aviv Stock Exchange (Tase)-listed NewMed Energy has gained momentum. Opposition is being led by 6.9% shareholder Palliser Capital, which claims 39% of shareholders back its proposal to remove the Capricorn board.

Tagged with:

Pin Strategy & risk

Want to read more?

Subscribe to African Energy

View subscription options

Don't have an account?

Register for access to our free content

An account also allows you to view selected free articles, set up news alerts, search our African Energy Live Data power projects database and view project locations on our interactive map

Register